VEGFA and cancer: Inappropriate angiogenesis is a key factor in a range of conditions including cancer and proliferative eye diseases; blockade of VEGFA signalling to inhibit angiogenesis and reduce vascular leakage forms the basis of multiple effective clinical treatments2.